Login / Signup

Serum protein and imaging biomarkers after intermittent steroid treatment in muscular dystrophy.

Alexander B WillisAaron S ZelikovichRobert SufitSenda Ajroud-DrissKrista VandenborneAlexis R DemonbreunAbhinandan BatraGlenn A WalterElizabeth M McNally
Published in: medRxiv : the preprint server for health sciences (2024)
At baseline compared to age and sex-matched healthy controls, the aggregate serum protein profile in the WSiMD cohort was dominated by muscle proteins, reflecting leak of muscle proteins into serum. Disease status produced more proteins differentially present in serum compared to steroid-treatment effect. Nonetheless, a response to prednisone was discernable in the WSiMD cohort, even at this low dose. Glucocorticoids downregulated muscle proteins and upregulated certain immune process- and matrix-associated proteins. Muscle MR fat fraction showed trends with functional status. The prednisone-responsive markers could be used in larger trial of prednisone efficacy.
Keyphrases
  • skeletal muscle
  • low dose
  • clinical trial
  • magnetic resonance imaging
  • study protocol
  • computed tomography
  • binding protein
  • protein protein
  • fatty acid
  • mass spectrometry
  • drug delivery
  • open label